SC 13D

Company

Caribou Biosciences, Inc.

Filed

February 4, 2022

Accession Number

0000950170-22-000764

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →